These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6634136)

  • 1. [Acetylator state in diabetes mellitus and ischemic heart disease].
    Rohla M; Várnai Z; Balázsi I
    Orv Hetil; 1983 Jul; 124(31):1865-6. PubMed ID: 6634136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic acetylator phenotype in diabetic polyneuropathy].
    Ladero Quesada JM; Arrojo Romero A; Cocero Oviedo E; Gómez Pérez M; Cano Iglesias F; Franco Carcedo C; Camarero González E; Sánchez Creus P
    Rev Clin Esp; 1983 Mar; 168(6):399-402. PubMed ID: 6878767
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum betaglucuronidase in ischemic heart diseases].
    De Neuman MP; Martiarena JL; Neumam J
    Medicina (B Aires); 1973; 33(2):123-32. PubMed ID: 4720170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of serum beta glucuronidase in normoglucemic or diabetic patients with coronary and peripheral vascular atheromatosis].
    De Neuman MP; Martiarena JL; Neuman J
    Prensa Med Argent; 1969 Dec; 56(40):1829-32. PubMed ID: 5374597
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotype in rheumatoid arthritis.
    Ehrenfeld M; Zylber-Katz E; Levy M
    Isr J Med Sci; 1983 Apr; 19(4):368-70. PubMed ID: 6853137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution pattern of acetylator phenotypes: effect of age].
    Gachályi B; Vas A; Hajös P; Káldor A
    Orv Hetil; 1984 Jan; 125(2):75-7. PubMed ID: 6694835
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acetylator phenotype and renal function on the antihypertensive effect of hydralazine.
    Koopmans PP; Hoefnagels WH; Huysmans FT; Thien T
    Neth J Med; 1984; 27(3):69-73. PubMed ID: 6709112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
    Bodnar PN; Donish RM; Buglak NI; Panasiukova OR
    Ter Arkh; 1983; 55(12):78-81. PubMed ID: 6665725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amount of acetone and ethyl alcohol in the blood and urine of patients with diabetes mellitus and ischemic heart disease].
    Kamysheva EP; Sorochkina RM; Kapatsinskaia LK; Romanova LN; Danilova MI
    Sov Med; 1976 Apr; (4):147-8. PubMed ID: 988639
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylator phenotype in Iraqi patients with discoid lupus erythematosus.
    Najim RA; Farid YY; Shihab SA
    Saudi Med J; 2004 Oct; 25(10):1530-2. PubMed ID: 15494852
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of histone and transcription factor acetylation in diabetes pathogenesis.
    Gray SG; De Meyts P
    Diabetes Metab Res Rev; 2005; 21(5):416-33. PubMed ID: 15906405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible acetylation of non histone proteins: role in cellular function and disease.
    Batta K; Das C; Gadad S; Shandilya J; Kundu TK
    Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acetylation processes in chronic alcoholics].
    Kovalev IE; Kovalev EN; Seleznev NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.
    Hein DW; Doll MA; Ferguson RJ
    Proc West Pharmacol Soc; 1995; 38():59-62. PubMed ID: 7480023
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ischemic heart disease and diabetes mellitus].
    Sokhor K
    Voen Med Zh; 1982 Nov; (11):58-9. PubMed ID: 7179789
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.